Instylla Announces Enrollment of Initial Patient in the Prospective Multicenter HALT Study
The HALT study is led by Dr. Suvranu Ganguli, Section Chief, Interventional Radiology, Boston Medical Center.
Florida / New York
Ph: 561.316.3330
View the latest clinical trials, studies, data, and updates.
The HALT study is led by Dr. Suvranu Ganguli, Section Chief, Interventional Radiology, Boston Medical Center.
INTRODUCTION: With the advent of technology and development, virtual clinical trials (VCTs) are gaining more and more popularity among patients and health care providers alike.
The Electroducer Sleeve® makes it simpler and safer to perform endovascular procedures requiring temporary cardiac pacing. Implanting a temporary pacemaker is the current conventional technique.
The Sphere-9 catheter combines mapping, navigation, and therapeutic capabilities and is the only catheter capable of delivering both RF and PF energies for ablation, providing physicians with the ability to customize treatment based on a patient’s needs during an ablation procedure advises Medtronic.
The trial by Bone Health Technologies was conducted in partnership with Laura Bilek, Ph.D., the Associate Dean for Research in the College of Allied Health Professions at the University of Nebraska Medical Center (UNMC) and expert in clinical research for the treatment of low bone mass.
Jeremy Harman, PA-C, an author of the study, commented, “The trifecta of breathable barrier protection, antimicrobials, and the ability to monitor the site is what makes this a great dressing. It’s easier for us to assess the wound and is more comfortable for patients.”
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330